Pascoe Richard W Insider Trades

Insider Trading History

Track insider trading activity for Pascoe Richard W. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $616 1,666 shares
Last Trade
Jan 04, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$284k 1,666 shares
$170.24
$0.37
Zevra Therapeutics
Zevra Therapeutics KMPH
Chief Executive Officer
Holding Value $174k 29,973 shares
Last Trade
Mar 09, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$58.1k 10,000 shares
$5.81
$5.81
Zevra Therapeutics
Zevra Therapeutics ZVRA
Chief Executive Officer
Holding Value $390k 29,973 shares
Last Trade
Mar 09, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$42k 10,000 shares
$4.20
$13.00
Zevra Therapeutics
Zevra Therapeutics KMPH
Chief Executive Officer
Holding Value $116k 19,973 shares
Last Trade
Jan 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$51.7k 9,500 shares
$5.44
$5.81
Zevra Therapeutics
Zevra Therapeutics ZVRA
Chief Executive Officer
Holding Value $260k 19,973 shares
Last Trade
Jan 13, 2023 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$13.00
Zevra Therapeutics
Zevra Therapeutics ZVRA
Chief Executive Officer
Holding Value $9.1M 700,000 shares
Last Trade
Jan 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$13.00
Zevra Therapeutics
Zevra Therapeutics KMPH
Chief Executive Officer
Holding Value $4.07M 700,000 shares
Last Trade
Jan 09, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.18M 700,000 shares
$4.54
$5.81
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $18.5k 50,000 shares
Last Trade
Jan 05, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$156M 50,000 shares
$3,113.51
$0.37
Zevra Therapeutics
Zevra Therapeutics ZVRA
Executive Chairman
Holding Value $108k 8,285 shares
Last Trade
May 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$13.00
Zevra Therapeutics
Zevra Therapeutics KMPH
Executive Chairman
Holding Value $48.1k 8,285 shares
Last Trade
May 18, 2022 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$24.7k 5,000 shares
$4.93
$5.81
Zevra Therapeutics
Zevra Therapeutics KMPH
Executive Chairman
Holding Value $740k 127,286 shares
Last Trade
Feb 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$913k 127,286 shares
$7.17
$5.81
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $13k 35,000 shares
Last Trade
Jan 05, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210M 35,000 shares
$5,996.39
$0.37
Zevra Therapeutics
Zevra Therapeutics KMPH
Executive Chairman
Holding Value $19.1k 3,285 shares
Last Trade
Nov 30, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$11.8k 1,500 shares
$7.88
$5.81
Zevra Therapeutics
Zevra Therapeutics KMPH
Executive Chairman
Holding Value $581k 100,000 shares
Last Trade
Nov 10, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$910k 100,000 shares
$9.10
$5.81
Zevra Therapeutics
Zevra Therapeutics KMPH
Director
Holding Value $87.2k 15,000 shares
Last Trade
Jun 17, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$232k 15,000 shares
$15.47
$5.81
Conatus Pharmaceuticals
Conatus Pharmaceuticals CNAT
President, CEO & Director
Holding Value $0 30,000 shares
Last Trade
Mar 30, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
No data
No data
$0.00
Histogen
Histogen HSTO
President, CEO & Director
Holding Value $600 30,000 shares
Last Trade
Mar 30, 2021 Purchase (Open Market)Shares bought on the open market or in a private purchase outside of a company compensation plan.
$452k 20,000 shares
$22.60
$0.02
Conatus Pharmaceuticals
Conatus Pharmaceuticals CNAT
President, CEO & Director
Holding Value $0 346,000 shares
Last Trade
Jan 13, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$0.00
Histogen
Histogen HSTO
President, CEO & Director
Holding Value $6.92k 346,000 shares
Last Trade
Jan 13, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.71M 346,000 shares
$19.40
$0.02
Seelos Therapeutics
Seelos Therapeutics SEEL
Director
Holding Value $5.92k 16,000 shares
Last Trade
Jan 06, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$83M 16,000 shares
$5,189.18
$0.37

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up